Unosi

• Bevacizumab in combination with irinotecan and capecitabine as first-line tretment for mCRC-efficacy and safety (2014)

  S. Jungić, G. Kecman-Malčić, I. Rakita, D. Jovanović, R. Gajanin, Z. Marić, B. Tubić, Z. Gojković, Bevacizumab in combination with irinotecan and capecitabine as first-line tretment for mCRC-efficacy and safety, Annals of Oncology, 2014